Nikolaus S - Search Results

1

Subclinical Pulmonary Involvement in Active IBD Responds to Biologic Therapy.

Ellrichmann M, Bethge J, Boesenkoetter J, Conrad C, Noth R, Bahmer T, Nikolaus S, Aden K, Zeissig S, Schreiber S. Ellrichmann M, et al. Among authors: nikolaus s. J Crohns Colitis. 2021 Aug 2;15(8):1339-1345. doi: 10.1093/ecco-jcc/jjab024. J Crohns Colitis. 2021. PMID: 33544122 Free PMC article.

2

Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.

Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasché C, Lochs H, Raedler A. Schreiber S, et al. Among authors: nikolaus s. N Engl J Med. 1996 Mar 7;334(10):619-23. doi: 10.1056/NEJM199603073341002. N Engl J Med. 1996. PMID: 8592524 Free article. Clinical Trial.

3

Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.

Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S. Nikolaus S, et al. Gut. 1998 Apr;42(4):470-6. doi: 10.1136/gut.42.4.470. Gut. 1998. PMID: 9616306 Free PMC article.

4

Activation of nuclear factor kappa B inflammatory bowel disease.

Schreiber S, Nikolaus S, Hampe J. Schreiber S, et al. Among authors: nikolaus s. Gut. 1998 Apr;42(4):477-84. doi: 10.1136/gut.42.4.477. Gut. 1998. PMID: 9616307 Free PMC article.

5

Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease.

Schreiber S, Nikolaus S, Hampe J, Hämling J, Koop I, Groessner B, Lochs H, Raedler A. Schreiber S, et al. Among authors: nikolaus s. Lancet. 1999 Feb 6;353(9151):459-61. doi: 10.1016/S0140-6736(98)03339-X. Lancet. 1999. PMID: 9989717

6

Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease.

Nikolaus S, Fölscn U, Schreiber S. Nikolaus S, et al. Hepatogastroenterology. 2000 Jan-Feb;47(31):71-82. Hepatogastroenterology. 2000. PMID: 10690587 Review.

7

Mechanisms in failure of infliximab for Crohn's disease.

Nikolaus S, Raedler A, Kühbacker T, Sfikas N, Fölsch UR, Schreiber S. Nikolaus S, et al. Lancet. 2000 Oct 28;356(9240):1475-9. doi: 10.1016/s0140-6736(00)02871-3. Lancet. 2000. PMID: 11081530 Clinical Trial.

8

Increased expression of IL-16 in inflammatory bowel disease.

Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S. Seegert D, et al. Among authors: nikolaus s. Gut. 2001 Mar;48(3):326-32. doi: 10.1136/gut.48.3.326. Gut. 2001. PMID: 11171821 Free PMC article.

9

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease.

Schreiber S, Nikolaus S, Malchow H, Kruis W, Lochs H, Raedler A, Hahn EG, Krummenerl T, Steinmann G; German ICAM-1 Study Group. Schreiber S, et al. Among authors: nikolaus s. Gastroenterology. 2001 May;120(6):1339-46. doi: 10.1053/gast.2001.24015. Gastroenterology. 2001. PMID: 11313303 Clinical Trial.

10

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG. Hampe J, et al. Among authors: nikolaus s. Lancet. 2001 Jun 16;357(9272):1925-8. doi: 10.1016/S0140-6736(00)05063-7. Lancet. 2001. PMID: 11425413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters